Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study

    Samah Ibrahim, Nehal Mohamed Zuelfakkar, Hadeel Asar, Ahmed Elhawatky
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Studysummary This case control study investigated serum IL-17A levels in alopecia areata patients compared to healthy controls to explore its potential role in the disease's pathogenesis.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results